Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

AIMS/HYPOTHESIS: The renal and cardiovascular protective effects of angiotensin receptor blocker (ARB) remain controversial in type 2 diabetic patients treated with a contemporary regimen including an angiotensin converting enzyme inhibitor (ACEI). METHODS: We examined the effects of olmesartan, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., Makino, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210358/
https://www.ncbi.nlm.nih.gov/pubmed/21993710
http://dx.doi.org/10.1007/s00125-011-2325-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210358/
https://www.ncbi.nlm.nih.gov/pubmed/21993710
http://dx.doi.org/10.1007/s00125-011-2325-z

Ejemplares similares